TY  - GEN
AU  - O'Dwyer,Michael E
AU  - Mauro,Michael J
AU  - Blasdel,Carolyn
AU  - Farnsworth,Melanie
AU  - Kurilik,Gwen
AU  - Hsieh,Yi-Ching
AU  - Mori,Motomi
AU  - Druker,Brian J
TI  - Clonal evolution and lack of cytogenetic response are adverse prognostic factors for hematologic relapse of chronic phase CML patients treated with imatinib mesylate
SN  - 0006-4971
PY  - 2004///0226
KW  - Adult
KW  - Aged
KW  - Benzamides
KW  - Blood Cell Count
KW  - Dose-Response Relationship, Drug
KW  - Female
KW  - Humans
KW  - Imatinib Mesylate
KW  - Immunosuppressive Agents
KW  - therapeutic use
KW  - Interferons
KW  - Leukemia, Myelogenous, Chronic, BCR-ABL Positive
KW  - drug therapy
KW  - Male
KW  - Middle Aged
KW  - Piperazines
KW  - Probability
KW  - Prognosis
KW  - Pyrimidines
KW  - Recurrence
KW  - Treatment Failure
N1  - Publication Type: Clinical Trial; Clinical Trial, Phase I; Clinical Trial, Phase II; Journal Article; Multicenter Study
UR  - https://doi.org/10.1182/blood-2003-02-0371
ER  -